4 - 氨基胺类类似物通过诱导细胞亡和依赖线粒体的细胞死亡途径来杀死莱什曼尼亚 (Leishmania) 亚马逊虫
Juliana da Trindade Granato1, Emerson Teixeira da Silva2, Ari Sérgio de Oliveira Lemos1
1Departamento de Parasitologia, Microbiologia e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
Chemical biology & drug design
|May 21, 2024
概括
一种新的氨酸化化合物MHZ15对导致皮肤莱什曼病的莱什曼亚马逊菌具有显著的疗效. 这种有前途的抗莱什曼药物具有低毒性和有利于药物开发的特征.
科学领域:
- 药用化学 医学化学
- 寄生虫学的寄生虫学
- 药物发现 药物发现 药物发现
背景情况:
- 莱什曼病的治疗选择有限.
- 迫切需要新型抗莱什曼病毒药物.
研究的目的:
- 评估一系列的利尼基胺类同类药物作为潜在的治疗莱什曼病.
- 为了识别和描述对莱什曼亚马逊菌最活跃的化合物.
主要方法:
- 合成和选15种氨酸化类似物.
- 在体外评估抗莱什曼的活性对前兆和前兆的形式.
- 对寄生虫对治疗反应的生物化学和超结构分析.
- 在皮肤莱什曼病的小鼠模型中进行了体内疗效研究.
- 在体内对化合物的毒性评估.
主要成果:
- 在低微分子度下,MHZ15对两种寄生虫形式都表现出强烈的活性.
- MHZ15对寄生虫对宿主细胞的选择性很高.
- 生物化学研究表明,MHZ15诱导了线粒体功能障碍,ROS生产和寄生虫的亡.
- 在体内研究表明,在没有观察到痛苦的感染小鼠中,寄生虫负荷显著减少.
- MHZ15没有显著的体内毒性,肝酶水平正常.
结论:
- MHZ15是一种高效和选择性的抗莱什曼尼化合物.
- 该化合物向关键的寄生虫通路,导致细胞死亡.
- MHZ15显示出作为皮肤莱什曼病治疗剂的开发潜力.
关键词:
莱什曼亚亚马逊人种 (Leishmania amazonensis) 是一个亚马逊人种.灭症 (apoptosis) 是一种死亡的过程.化的含量是多少 化线粒体功能障碍 线粒体功能障碍鼠类皮肤雷什曼病 鼠类皮肤雷什曼病昆氨酸 (quinoline) 是一种氨酸.更多相关视频
08:48Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
11.8K
10:01Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites
Published on: March 16, 2018
10.5K
相关概念视频
Inhibitors of Bacterial DNA Synthesis
130
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
130
Anthelminthic Agents
103
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
103
